Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Blackledge

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Academic Radiology|July 12, 2025
Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107]Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Insights Into Imaging|July 28, 2022
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myelomaMihaela Rata, Matthew Blackledge, Erica Scurr, et al.
Ebiomedicine|November 12, 2022
A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodulesBenjamin Hunter, Mitchell Chen, Prashanthi Ratnakumar, et al.
The British Journal of Radiology|October 28, 2017
UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancerAnna Barnes, Roberto Alonzi, Matthew Blackledge, et al.
Insights Into Imaging|October 15, 2023
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma studySam Keaveney, Alina Dragan, Mihaela Rata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2024
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitisSumeet Hindocha, Benjamin Hunter, Kristofer Linton-Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastomaCrescens Tiu, Wing Yau, Diogo Silva, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Academic Radiology|July 12, 2025
Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107]Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Insights Into Imaging|July 28, 2022
Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myelomaMihaela Rata, Matthew Blackledge, Erica Scurr, et al.
Ebiomedicine|November 12, 2022
A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodulesBenjamin Hunter, Mitchell Chen, Prashanthi Ratnakumar, et al.
The British Journal of Radiology|October 28, 2017
UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancerAnna Barnes, Roberto Alonzi, Matthew Blackledge, et al.
Insights Into Imaging|October 15, 2023
Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma studySam Keaveney, Alina Dragan, Mihaela Rata, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2024
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitisSumeet Hindocha, Benjamin Hunter, Kristofer Linton-Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastomaCrescens Tiu, Wing Yau, Diogo Silva, et al.
Pageof 4